NCT00476541View on ClinicalTrials.gov

NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Gemtuzumab ozogamicin

Two courses of Gemtuzumab vs. no further therapy

Trial Locations (2)

2100

Rigshospitalet, Copenhagen

8200

Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT00476541 - NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter